Bank of America’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.22M Buy
548,090
+15,206
+3% +$173K ﹤0.01% 3132
2025
Q1
$3.54M Buy
532,884
+523,793
+5,762% +$3.48M ﹤0.01% 3504
2024
Q4
$100K Sell
9,091
-115,557
-93% -$1.27M ﹤0.01% 5525
2024
Q3
$1.53M Buy
124,648
+26,850
+27% +$330K ﹤0.01% 4026
2024
Q2
$1.32M Buy
97,798
+69,191
+242% +$935K ﹤0.01% 4023
2024
Q1
$386K Sell
28,607
-46,732
-62% -$631K ﹤0.01% 4689
2023
Q4
$396K Buy
75,339
+17,781
+31% +$93.5K ﹤0.01% 4772
2023
Q3
$227K Buy
57,558
+37,211
+183% +$147K ﹤0.01% 4983
2023
Q2
$216K Sell
20,347
-5,185
-20% -$55.1K ﹤0.01% 4957
2023
Q1
$213K Buy
25,532
+520
+2% +$4.33K ﹤0.01% 5124
2022
Q4
$231K Buy
25,012
+19,161
+327% +$177K ﹤0.01% 5114
2022
Q3
$75K Sell
5,851
-10,471
-64% -$134K ﹤0.01% 5657
2022
Q2
$215K Buy
16,322
+7,690
+89% +$101K ﹤0.01% 5287
2022
Q1
$182K Sell
8,632
-45,110
-84% -$951K ﹤0.01% 5767
2021
Q4
$1.29M Buy
53,742
+45,345
+540% +$1.09M ﹤0.01% 4305
2021
Q3
$214K Sell
8,397
-3,926
-32% -$100K ﹤0.01% 5424
2021
Q2
$415K Sell
12,323
-488
-4% -$16.4K ﹤0.01% 4844
2021
Q1
$497K Buy
12,811
+9,282
+263% +$360K ﹤0.01% 4758
2020
Q4
$219K Sell
3,529
-454
-11% -$28.2K ﹤0.01% 4831
2020
Q3
$134K Sell
3,983
-5,173
-56% -$174K ﹤0.01% 4913
2020
Q2
$218K Buy
9,156
+3,307
+57% +$78.7K ﹤0.01% 4648
2020
Q1
$134K Buy
5,849
+2,236
+62% +$51.2K ﹤0.01% 4769
2019
Q4
$102K Sell
3,613
-101
-3% -$2.85K ﹤0.01% 5176
2019
Q3
$79K Buy
+3,714
New +$79K ﹤0.01% 5333